# Tianneng Jingxiu

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tianneng-jingxiu

- Industry: Agribusiness
- Headquarters: Chengdu, China
- Latest round: Series A (Jul 13, 2026)
- Investors on record: 5

## About

Based in Chengdu, China, and founded in 2023, Sichuan Tianneng Jingxiu Biotechnology Co., Ltd., trading as Tianneng Jingxiu, is an agricultural biotechnology developer, primarily engaged in the research and development of hybrid maize nuclear male sterility seed production technology to improve maize yield. In July 2026, Tianneng Jingxiu raised a Series A funding from Geuniom Group, Tianfu Science and Technology Venture Capital, Molbreeding Biotechnology Co., Ltd., Dinghao Development Equity Investment Fund Management and Starlight Capital.

The company provides proprietary nuclear male sterility breeding technology, sterile line propagation services, and breeding conversion services that enable hybrid corn seed producers to eliminate manual detasseling and improve seed purity, yield, and production efficiency.

The company generates revenue by providing sterile line propagation and breeding conversion services and commercializing its proprietary nuclear male sterility technology for hybrid corn seed production.

The Series A funding raised in July 2026 will enable Tianneng Jingxiu to move from technology verification to large-scale development. 
In the next three years, the company will accelerate the layout of core seed production bases nationwide, promoting the expansion of sterile line propagation areas from thousands of acres to tens of thousands of acres. Simultaneously, it will expedite the approval of safety certificates to seize the window of opportunity for the industrialization of bio-breeding.

## Funding rounds

- Series A, Jul 13, 2026 — Dinghao Development Equity Investment Fund Management, Molbreeding Biotechnology Co., Ltd., Starlight Capital, Geuniom Group, Tianfu Science and Technology Venture Capital

## Investors

- Dinghao Development Equity Investment Fund Management (https://capitalatlas.ai/funds/dinghao-development-equity-investment-fund-management) — Series A
- Molbreeding Biotechnology Co., Ltd. — Series A
- Starlight Capital (https://capitalatlas.ai/funds/starlight-capital) — Series A
- Geuniom Group — Series A
- Tianfu Science and Technology Venture Capital (https://capitalatlas.ai/funds/tianfu-science-and-technology-venture-capital) — Series A